BEDMINSTER, N.J.--(BUSINESS WIRE)--Dendrite International, Inc. (NASDAQ:DRTE), a leading provider of pharmaceutical industry solutions, today announced a strategic relationship with Microsoft Corp. (NASDAQ: MSFT) aimed at developing new Dendrite solutions on the Microsoft software platform.
